Purple Biotech Reports Fourth Quarter and Full-Year 2022 Financial Results

February 8, 2023

https://www.globenewswire.com/news-release/2023/02/08/2603812/0/en/Purple-Biotech-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-Results.html

Expands pipeline with acquisition of new tri-specific antibodies
Data readouts for two lead clinical programs expected in 2023

REHOVOT, Israel, Feb. 08, 2023 (GLOBE NEWSWIRE) — Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class, effective and durable therapies that harness the power of the tumor microenvironment to overcome tumor immune evasion and drug resistance, today announced financial results for the year and the three months ended December 31, 2022.

Read more at globenewswire.com

Related news for (PPBT)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.